Authors : Chavan Akshay Sukhadev; Dr. Pushpendra Tiwari

Volume/Issue : Volume 10 - 2025, Issue 4 - April

Google Scholar : https://tinyurl.com/mtp82uej

Scribd : https://tinyurl.com/55se2rat

DOI : https://doi.org/10.38124/ijisrt/25apr1824

Google Scholar

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 15 to 20 days to display the article.

Abstract : Neurodegenerative illnesses are progressive and have few available treatments, they pose serious global health issues. Examples of these diseases are Alzheimer's, Parkinson's, and Huntington's. This work synthesizes and characterizes new heterocyclic compounds with neuroprotective characteristics in order to solve these problems. These compounds were produced by a sequence of chemical processes and examined using sophisticated spectroscopic methods like mass spectrometry, IR, and NMR. They are well-known for their structural diversity and biological activity. Their capacity to prevent neuronal cell death, lessen oxidative stress, and alter important signaling pathways involved in neurodegeneration was demonstrated during tests of their neuroprotective efficacy both in vitro and in vivo. According to preliminary findings, a number of these substances have notable neuroprotective properties, highlighting their potential as therapeutic possibilities. Through important insights into the design and development of therapeutic medicines targeting the causes of neuronal damage and dysfunction, this research contributes to the hunt for effective treatments for neurodegenerative diseases.

Keywords : Synthesis, Characterization, Heterocyclic, Compounds, Neuroprotective, Properties Neurodegenerative, Disease, Treatment.

References :

1. Alghamdi, S., Kabrah, A., Khidir, E. B., Al-Moraya, I. S., & Asif, M. (2023). Diverse Heterocyclic Molecules Targeting Oxidative Stress as Therapeutic Effects Against Various Neurological Diseases. Mini-Reviews in Organic Chemistry, 20.
2. Barresi, E., Baglini, E., Poggetti, V., Castagnoli, J., Giorgini, D., Salerno, S., ... & Da Settimo, F. (2024). Indole-Based Compounds in the Development of Anti-Neurodegenerative Agents. Molecules, 29(9), 2127.
3. Chauhan, M. S. S., Umar, T., & Aulakh, M. K. (2023). Quinolines: Privileged Scaffolds for Developing New Anti‐neurodegenerative Agents. ChemistrySelect, 8(14), e202204960.
4. Das, S., Akbar, S., Ahmed, B., Dewangan, R. P., Iqubal, M. K., Iqubal, A., ... & Joseph, A. (2022). Recent advancement of pyrazole scaffold based neuroprotective agents: A review. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders), 21(10), 940-951.
5. Eliewi, A. G., Al-Garawi, Z. S., Al-Kazzaz, F. F., & Atia, A. J. K. (2021, March). Multi target-directed imidazole derivatives for neurodegenerative diseases. In Journal of Physics: Conference Series (Vol. 1853, No. 1, p. 012066). IOP Publishing.
6. Elmabruk, A., Das, B., Yedlapudi, D., Xu, L., Antonio, T., Reith, M. E., & Dutta, A. K. (2018). Design, synthesis, and pharmacological characterization of carbazole based dopamine agonists as potential symptomatic and neuroprotective therapeutic agents for Parkinson’s disease. ACS Chemical Neuroscience, 10(1), 396-411.
7. Gulcin, İ., Petrova, O. V., Taslimi, P., Malysheva, S. F., Schmidt, E. Y., Sobenina, L. N., ... & Sujayev, A. R. (2022). Synthesis, Characterization, Molecular Docking, Acetylcholinesterase and α‐Glycosidase Inhibition Profiles of Nitrogen‐Based Novel Heterocyclic Compounds. ChemistrySelect, 7(19), e202200370.
8. Kondeva-Burdina, M., Mateev, E., Angelov, B., Tzankova, V., & Georgieva, M. (2022). In silico evaluation and in vitro determination of neuroprotective and MAO-B inhibitory effects of pyrrole-based hydrazones: A therapeutic approach to Parkinson’s disease. Molecules, 27(23), 8485.
9. Landgraf, A. D., Alsegiani, A. S., Alaqel, S., Thanna, S., Shah, Z. A., & Sucheck, S. J. (2020). Neuroprotective and anti-neuroinflammatory properties of ebselen derivatives and their potential to inhibit neurodegeneration. ACS chemical neuroscience, 11(19), 3008-3016.
10. Li, X., Yu, Y., & Tu, Z. (2021). Pyrazole scaffold synthesis, functionalization, and applications in Alzheimer’s disease and Parkinson’s disease treatment (2011–2020). Molecules, 26(5), 1202.
11. Michalska, P., Mayo, P., Fernández-Mendívil, C., Tenti, G., Duarte, P., Buendia, I., ... & León, R. (2020). Antioxidant, anti-inflammatory and neuroprotective profiles of novel 1, 4-dihydropyridine derivatives for the treatment of Alzheimer’s disease. Antioxidants, 9(8), 650.
12. Özdemir, A., Sever, B., Altıntop, M. D., Kaya Tilki, E., & Dikmen, M. (2018). Design, synthesis, and neuroprotective effects of a series of pyrazolines against 6-hydroxydopamine-induced oxidative stress. Molecules, 23(9), 2151.
13. Ramaiah, M. J., Karthikeyan, D., Mathavan, S., Yamajala, R. B., Ramachandran, S., Vasavi, P. J., & Chandana, N. V. (2020). Synthesis, in vitro and structural aspects of benzothiazole analogs as anti-oxidants and potential neuroprotective agents. Environmental Toxicology and Pharmacology, 79, 103415.
14. Tapias, V., González-Andrés, P., Peña, L. F., Barbero, A., Núñez, L., & Villalobos, C. (2023). Therapeutic potential of heterocyclic compounds targeting mitochondrial calcium homeostasis and signaling in alzheimer’s disease and Parkinson’s disease. Antioxidants, 12(6), 1282.
15. Tzankova, D., Aluani, D., Kondeva-Burdina, M., Georgieva, M., Vladimirova, S., Peikova, L., & Tzankova, V. (2022). Antioxidant properties, neuroprotective effects and in vitro safety evaluation of new pyrrole derivatives. Pharmaceutical Chemistry Journal, 55(12), 1310-1319.